Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $1.7 million.

  • cbdMD's Gains from Investment Securities changed N/A to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 397261.46%. This contributed to the annual value of $599521.0 for FY2025, which is 7317.34% up from last year.
  • Per cbdMD's latest filing, its Gains from Investment Securities stood at $1.7 million for Q3 2025.
  • In the past 5 years, cbdMD's Gains from Investment Securities registered a high of $8.9 million during Q1 2021, and its lowest value of -$6.9 million during Q2 2021.
  • For the 5-year period, cbdMD's Gains from Investment Securities averaged around -$2316.5, with its median value being -$44771.0 (2023).
  • As far as peak fluctuations go, cbdMD's Gains from Investment Securities tumbled by 1473274.23% in 2021, and later surged by 176970.41% in 2024.
  • Quarter analysis of 5 years shows cbdMD's Gains from Investment Securities stood at $660417.0 in 2021, then plummeted by 109.24% to -$61000.0 in 2022, then fell by 14.35% to -$69752.0 in 2023, then skyrocketed by 1769.7% to $1.2 million in 2024, then soared by 47.99% to $1.7 million in 2025.
  • Its Gains from Investment Securities was $1.7 million in Q3 2025, compared to $1.2 million in Q4 2024 and -$4828.0 in Q1 2024.